A Rare Case of Bullous Pemphigoid Secondary to Checkpoint Inhibitor Immunotherapy: A Tense Situation

Bullous pemphigoid is a serious and rare complication of immunotherapy. Here, we present a case of bullous pemphigoid secondary to ipilimumab/nivolumab checkpoint inhibitor therapy in a patient with metastatic melanoma. Immune checkpoint inhibitor therapy is more widely used now to treat cancer pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Wesolow, Jacqueline T, Jalali, Samuel, Clark, Leah D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336291/
https://www.ncbi.nlm.nih.gov/pubmed/34367779
http://dx.doi.org/10.7759/cureus.16169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336291/
https://www.ncbi.nlm.nih.gov/pubmed/34367779
http://dx.doi.org/10.7759/cureus.16169

Ejemplares similares